| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |